This document is a report summarizing the analysis of a sample named Leveti racetam_Di sso_STD. It provides information about the sample name, acquisition method, injection volume, processing channel, and run time. The report details that the sample contained one peak identified as Levetiracetam, which eluted at 5.957 minutes, accounted for 100% of the total area, and met method validation criteria for plate count and tailing.
This document is a report summarizing the analysis of a sample named Leveti racetam_Di sso_STD. It provides information about the sample name, acquisition method, injection volume, processing channel, and run time. The report details that the sample contained one peak identified as Levetiracetam, which eluted at 5.957 minutes, accounted for 100% of the total area, and met method validation criteria for plate count and tailing.
This document is a report summarizing the analysis of a sample named Leveti racetam_Di sso_STD. It provides information about the sample name, acquisition method, injection volume, processing channel, and run time. The report details that the sample contained one peak identified as Levetiracetam, which eluted at 5.957 minutes, accounted for 100% of the total area, and met method validation criteria for plate count and tailing.
Proj ect Name: Master_JUN_2014\PARC_ARD_002 17-07-2014 Date Pri nted: 18:51:20 Asi a/Cal cutta Page: 1 of 1 S A M P L E I N F O R M A T I O N Leveti racetam_Di sso_STD General Sampl e Name: Acqui red By: Leveti racetam_28062014 Sampl e Set Name: 3 Vi al : Acq. Method Set: Leveti racetam_Mth 1 Inj ecti on #: Leveti racetam_proc Processi ng Method: 5.00 ul Inj ecti on Vol ume: W2489 ChA 205nm Proc. Chnl . Descr.: Run Ti me: 10.0 Mi nutes Sampl eName: Leveti racetam_Di sso_STD; Vi al : 3; Inj ecti on: 1; Channel : W2489 ChA; Date Acqui red: 28-06-2014 12:09:13 IST 5 . 9 5 7 1 Name Injection Area (V*sec) Retention Time (min) % Area USP Plate Count USP Tailing Int Type Levetiracetam 1 3154220 5.957 100.00 9032 1.54 BB Component Summary Table